Prospective observations study protocol to investigate cost-effectiveness of various prenatal test strategies after the introduction of noninvasive prenatal testing

[1]  L. Chitty,et al.  Uptake, outcomes, and costs of implementing non-invasive prenatal testing for Down’s syndrome into NHS maternity care: prospective cohort study in eight diverse maternity units , 2016, British Medical Journal.

[2]  Anjali J Kaimal,et al.  Prenatal Testing in the Genomic Age: Clinical Outcomes, Quality of Life, and Costs , 2015, Obstetrics and gynecology.

[3]  Committee Opinion No. 640: Cell-Free Dna Screening For Fetal Aneuploidy , 2015, Obstetrics and gynecology.

[4]  Brian R. Jackson,et al.  A Cost-Effectiveness Analysis of First Trimester Non-Invasive Prenatal Screening for Fetal Trisomies in the United States , 2015, PloS one.

[5]  Ken Song,et al.  Prenatal screening for fetal aneuploidies with cell-free DNA in the general pregnancy population: a cost-effectiveness analysis , 2015, The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians.

[6]  K. Nicolaides,et al.  Analysis of cell‐free DNA in maternal blood in screening for fetal aneuploidies: updated meta‐analysis , 2015, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.

[7]  S. Warsof,et al.  Uptake of noninvasive prenatal testing at a large academic referral center. , 2014, American journal of obstetrics and gynecology.

[8]  S. Oh,et al.  Changes in the Cesarean Section Rate in Korea (1982-2012) and a Review of the Associated Factors , 2014, Journal of Korean medical science.

[9]  J. Whitty,et al.  A cost‐effectiveness analysis comparing different strategies to implement noninvasive prenatal testing into a Down syndrome screening program , 2014, The Australian & New Zealand journal of obstetrics & gynaecology.

[10]  Hanmin Lee,et al.  Non-Invasive Chromosomal Evaluation (NICE) Study: results of a multicenter prospective cohort study for detection of fetal trisomy 21 and trisomy 18. , 2012, American journal of obstetrics and gynecology.

[11]  R. Rava,et al.  Genome-Wide Fetal Aneuploidy Detection by Maternal Plasma DNA Sequencing , 2012, Obstetrics and gynecology.

[12]  Argyro Syngelaki,et al.  Chromosome-selective sequencing of maternal plasma cell-free DNA for first-trimester detection of trisomy 21 and trisomy 18. , 2012, American journal of obstetrics and gynecology.

[13]  Arnold Oliphant,et al.  Noninvasive prenatal detection and selective analysis of cell-free DNA obtained from maternal blood: evaluation for trisomy 21 and trisomy 18. , 2012, American journal of obstetrics and gynecology.

[14]  S. Nelson,et al.  DNA sequencing of maternal plasma to detect Down syndrome: An international clinical validation study , 2011, Genetics in Medicine.

[15]  A. Ranzi,et al.  Age‐specific risk of fetal loss post second trimester amniocentesis: analysis of 5043 cases , 2007, Prenatal diagnosis.

[16]  F. Malone,et al.  Pregnancy Loss Rates After Midtrimester Amniocentesis , 2006, Obstetrics and gynecology.

[17]  A. Rudnicka,et al.  First-trimester or second-trimester screening, or both, for Down's syndrome. , 2005, The New England journal of medicine.

[18]  Charles Normand,et al.  Clinical outcomes, quality of life, and costs in the North Thames Dialysis Study of elderly people on dialysis: a prospective cohort study , 2000, The Lancet.

[19]  L. Shulman.  Chromosome-selective sequencing of maternal plasma cell–free DNA for first-trimester detection of trisomy 21 and trisomy 18 , 2012 .

[20]  ACOG Practice Bulletin No. 77: screening for fetal chromosomal abnormalities. , 2007, Obstetrics and gynecology.

[21]  北村 聖.  "The New England Journal of Medicine". , 1962, British medical journal.